GGrantIndex
← Leaderboards

Manu S Goyal

Washington University

$7,764,823
Attributed
$18,554,141
Total exposure
9
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.5M · FY201725
$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$18,554,141 · 9

By mechanism

RF1$13,175,660 · 5
R01$5,085,057 · 3
R21$293,424 · 1

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Alzheimer&Apos

Research focus

Alzheimer&AposS DiseaseBrainIn VivoImageNerve DegenerationMetabolicOxygenCohortGlucoseMeasurementMetabolismAffectAgingImpaired CognitionMagnetic Resonance ImagingCognitiveResolutionAging BrainAerobic GlycolysisBrain MetabolismAdultBrain RegionCerebrovascular Circulation

Grant awards (13)

White Matter Metabolism in the Context of Aging, White Matter Hyperintensities and Alzheimer's Disease$705,859
R01 · FY2025 · AG
Imaging and Reversibility of Cellular and Network Metabolic Dysfunction in Alzheimer's Disease$700,828
R01 · FY2025 · AG · contact PI
VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD$4,361,625
RF1 · FY2024 · NS
Brain metabolism during task-evoked and spontaneous activity in aging and Alzheimer's disease$2,289,625
RF1 · FY2023 · AG
Deep-Learning-Augmented Quantitative Gradient Recalled Echo (DLA-qGRE) MRI for in vivo Clinical Evaluation of Brain Microstructural Neurodegeneration in Alzheimer Disease$1,991,759
RF1 · FY2023 · AG
White Matter Metabolism in the Context of Aging, White Matter Hyperintensities and Alzheimer's Disease$2,287,856
RF1 · FY2022 · AG
Imaging and Reversibility of Cellular and Network Metabolic Dysfunction in Alzheimer's Disease$2,244,795
RF1 · FY2022 · AG · contact PI
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$690,801
R01 · FY2021 · AG
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$731,109
R01 · FY2020 · AG
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$745,594
R01 · FY2019 · AG
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$752,185
R01 · FY2018 · AG
Feasibility of challenge-free QSM based quantitative mapping of cerebral metabolic rate of oxygen$293,424
R21 · FY2018 · EB
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$758,681
R01 · FY2017 · AG